N-Methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA) glutamate-receptor antagonists have different interactions with the discriminative stimuli of abused drugs

Psychopharmacology

Volumn 128, Issue 3, 1996, Pages 320-327

  Jackson, Anne ^a   Brown, Geraldine ^a   Stephens, David N ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Dizocilpine; Drug discrimination; Excitatory amino acids; GYKI 52466; Ketamine; Morphine; NBQX; Substance abuse

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; FOOD; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; STIMULUS GENERALIZATION;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MORPHINE; NARCOTIC ANTAGONISTS; QUINOXALINES; RATS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; REINFORCEMENT SCHEDULE;

EID: 0029805124     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050140     Document Type: Article

References (40)

1. Balster RL, Johanson CE, Harris RT, Schuster CR (1973) Phencyclidine self-administration in the rhesus monkey. Pharmacol Biochem Behav 1:167-172
2. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115 : 516-528
3. Cappendijk SL, de Vries R, Dzoljic MR (1993) Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Eur Neuropsychopharmacol 3 : 111-116
4. Carroll ME, Meisch RA (1980) Oral phencyclidine (PCP) self-administration in rhesus monkeys: effects of feeding conditions. J Pharmacol Exp Ther 214 : 339-346
5. Cervo L, Sumanin R (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673: 242-250
6. Chapman AG, Smith SE, Meldrum BS (1991) The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res 9 : 92-96
7. Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J (1987) Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neural Sci 10 : 273-280
8. Freed WJ (1994) Glutamatergic mechanisms mediating stimulant and antipsyehotic drug effects. Neurosci Biobehav Rev 18: 111-120
9. Hauber W, Andersen R (1993) The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine. Naunyn-Schmiedeberg's Arch Pharmacol 348: 486-490
10. Honore T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE (1988) Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science 241 : 701-703
11. Hutson PA, Bristow LJ, Thorn L, Tricklebank MD (1991) R-(+)-HA-966, a glycine NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine. Br J Pharmacol 103 : 2037-2044
12. Jackson A, Sanger DJ (1988) Is the discriminative stimulus produced by phenyclidine due to an interaction with N-methyl-D-aspartate receptors. Psychopharmacology 96 : 87-92
13. Jackson A, Koek W, Colpaert FC (1992) NMDA antagonists make learning and recall state-dependent. Behav Pharmacol 3: 415-421
14. Kaddis FG, Uretsky NJ, Wallace LJ (1995) DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference. Brain Res 697 : 76-82
15. Kalivas PW, Duffy P, Barrow J (1989) Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 251 : 378-387
16. Karler R, Calder LD, Turkanis SA (1991) DNQX blockade of amphetamine behavioral sensitization. Brain Res 552 : 295-300
17. Koek W, Colpaert FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA) induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioural effects. J Pharmacol Exp Ther 252 : 349-357
18. Koek W, Woods JH, Ornstein P (1986) Phencyclidine-like behavioural effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate. Life Sci 39 : 973-978
19. Koek W, Colpaert FC, Vignon J (1993) Effects of phencyclidinetype drugs in rats discriminating fentanyl from saline: pharmacological and behavioural characterisation of intermediate levels of drug lever selection. J Pharmacol Exp Ther 264: 746-755
20. Layer RT, Uretsky NJ, Wallace LL (1993) Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res 617 : 267-273
21. Lees GJ (1996) Therapeutic potential of AMPA receptor ligands in neurological disorders. CNS Drugs 5 : 51-74
22. Meldrum BS, Chapman AG (1983) Excitatory amino acids and anticonvulsant drug action. In: Hertz E, Kvamme E, McGeer E, Schousboe A (eds) Glutamine, glutamate and GABA in the central nervous system. Liss, N.Y., pp 625-641
23. Meldrum B, Garthwaite J (1991) Excitatory amino acid neurotoxicity and neurodegenerative disease. In: Lodge D, Collingridge GL (eds) The pharmacology of excitatory amino acids. TIPS Special Report, Elsevier, UK, pp 18-24
24. Nicholls DG (1993) The glutamatergic nerve terminal. Eur J Biochem 212 : 613-631
25. Parada J, Czuczwar SJ, Turski WA (1992) NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil. Cognit Brain Res 1 : 67-71
26. Rocha BA, Ward AS, Egilmez Y, Lytle DA, Emmett-Oglesby MW (1996) Tolerance to the discriminative stimulus and reinforcing effects of ketamine. Behav Pharmacol 7 : 160-168
27. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247 : 571-247
28. Shoaib M, Spanagel R (1994) Mesolimbic sites mediate the discriminative stimulus effects of morphine. Eur J Pharmacol 252 : 69-75
29. Snyder SH (1980) Phencyclidine. Nature 285 : 355-356
30. Stephens DN, Cole BJ (1996) AMPA antagonists differ from NMDA antagonists in their effects on DRL and delayed matching to position tasks. Psychopharmacology 126 : 249-259
31. Steppuhn KG, Turski L (1993) Diazepam dependence prevented by glutamate antagonists. Proc Natl Acad Sci USA 90 : 6889-6893
32. Swedberg MDB, Jacobsen P, Honore T (1995) Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamyl-benzo (f) quinoxaline (NBQX). J Pharmacol Exp Ther 274 : 1113-1121
33. Tarnawa I, Farkas S, Berzsenyi P, Pataki S, Andrasi F (1989) Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466. Eur J Pharmacol 167 : 193-199
34. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 : 85-87
35. Turski L, Jacobsen P, Honore T, Stephens DN (1992) Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. J Pharmacol Exp Ther 260 : 742-747
36. Wang T, French ED (1995) NMDA, kainate and AMPA depolarise nondopamine neurons in the rat VTA. Brain Res Bull 36 : 39-43
37. Willins DL, Wallace LJ, Miller DD, Uretsky NJ (1992) α-Amino-3-hydroxy-methylisoxazole-4-proprionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs. J Pharmacol Exp Ther 260 : 1145-1151
38. Witkin JM (1993) Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci 53 : 405-410
39. Woods JH, Winger G, Pakarinen E, Aspen J (1995) Reinforcing effects of NMDA antagonists in rhesus monkeys. Behav Pharmacol 6 : 636-637
40. Young AB, Fagg GE (1991) Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. In: Lodge D, Collingridge GL (eds) The pharmacology of excitatory amino acids. TIPS Special Report, Elsevier, UK, pp 18-24